Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G SAQsGynaecological health — adnexal pathology

O&G SAQs · Gynaecological health — adnexal pathology

Adnexal mass — structured SAQ (15 marks)

FRANZCOG-format structured SAQ on the adnexal mass at initial imaging: IOTA Simple Rules characterisation with validated performance, the tumour-marker pitfall in pregnancy, the decidualised endometrioma as the great mimic, and the emergency recognition and management of ovarian torsion. Per-sub-part marking rubric included.

15 marks20 min4 min readVerification in progress

Target exams

FRANZCOGMRCOGABOG
On this page
Study tools

Target exams

FRANZCOGMRCOGABOG
Prompt
A 34-year-old nulligravida, 10 weeks into an IVF pregnancy, is found at her dating scan to have a 6 cm right adnexal mass with papillary projections and colour Doppler flow. She has known endometriosis and is asymptomatic. (a) Describe how you would characterise this mass sonographically, naming the structured system you would use and its validated performance. (4 marks) (b) State what is wrong with sending a routine tumour marker panel in pregnancy, and give the physiological explanation. (3 marks) (c) Give the most likely diagnosis, the supporting evidence from the pregnancy-specific literature, and the appropriate management. (4 marks) (d) Two weeks later she re-presents with sudden severe right iliac fossa pain and vomiting. Outline your immediate management. (4 marks)

How this SAQ is marked

Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: the named scoring system with numbers, the named study, the absolute outcomes, and the right decision at the right time. Answer the sub-part you are asked, in short labelled points. [1]

Reveal model answer and mark schemeShowHide

(a) Sonographic characterisation (4 marks)

One mark for naming the system; one for the B and M features; one for the application rule; one for the validated performance. [1][2]

  • I would characterise the mass using the International Ovarian Tumour Analysis (IOTA) Simple Rules, escalating to the ADNEX model or expert subjective assessment if the Simple Rules were inconclusive.
  • Five B features (predict benign): unilocular cyst; solid components under 7 mm in largest diameter; acoustic shadows; smooth multilocular tumour under 100 mm; no detectable blood flow. Five M features (predict malignant): irregular solid tumour; ascites; at least four papillary structures; irregular multilocular solid tumour 100 mm or more; very high colour content.
  • Application rule: one or more M and no B classifies malignant; the reverse classifies benign; both or neither is inconclusive, and the next step is expert subjective assessment or ADNEX (10% malignancy threshold).
  • Validated performance: in the Timmerman prospective validation of 1938 masses, the Simple Rules were conclusive in 77%, with sensitivity 92% and specificity 96%; ADNEX carries a summary AUC of 0.93 for benign versus malignant across 47 external validation studies.[1][2][3]

(b) Tumour markers in pregnancy (3 marks)

One mark for the principle; two for the physiological explanation. [4]

  • A tumour marker panel — CA-125, AFP, hCG, inhibin, LDH — should not be sent routinely on a sonographically characterised mass in pregnancy; it is uninterpretable and will drive wrong decisions.
  • CA-125 is expressed by peritoneum, decidua and amniotic fluid and rises physiologically, particularly in the first trimester and at delivery — a mid-range value tells you nothing about the mass.
  • AFP, hCG and inhibin are produced by the pregnancy itself; LDH is non-specific. Interpret only extreme values or a rising trend; trust the imaging, not the panel.[4]

(c) Most likely diagnosis and management (4 marks)

One mark for the diagnosis; two for the supporting evidence; one for the management. [4]

  • Most likely diagnosis: a decidualised endometrioma — papillary projections with Doppler flow in a woman with known endometriosis, in pregnancy. This is the great mimic of this topic.
  • Supporting evidence: in the Barcroft pregnancy-specific two-step IOTA pilot of 291 pregnant women, presumed decidualisation occurred in 31.1% of endometriomas and had resolved in 89.5% by the first postnatal scan; the ADNEX model misclassified 34% of benign masses as malignant, over half of which were decidualised endometriomas. Decidualisation is progesterone-driven stromal change producing vascular papillary projections that mimic the M features of malignancy.
  • Management: resist surgery; use expert subjective assessment and serial imaging; rescan postnatally. Counsel that this is a mimic, not a cancer. If MRI is needed for problem-solving, it must be non-contrast — gadolinium is out at any gestation.[4]

(d) Sudden pain and vomiting (4 marks)

One mark for the diagnosis; three for the management. [5][6]

  • Diagnosis: ovarian torsion until proven otherwise. Sudden severe unilateral lower abdominal pain with vomiting in a woman with a known adnexal mass — and an IVF pregnancy, where nearly half of torsion cases cluster — is torsion; ovarian salvage is time-critical.
  • Immediate actions: analgesia, intravenous access, bloods including group and save, nil by mouth, anaesthetic review, alert theatre, document the fetal heart before surgery.
  • Operation: laparoscopic detorsion with ovarian conservation — a dusky torted ovary usually recovers; oophorectomy is reserved for confirmed necrosis. Technique in pregnancy: entry sited above the fundus, insufflation 12 to 15 mmHg or less, capnography, left lateral tilt, minimal uterine manipulation.
  • Outcome counselling: obstetric outcomes are favourable — live birth around 92% and preterm delivery around 19% in Dvash's cohort; laparoscopy for adnexal surgery in pregnancy shows no significant increase in miscarriage or preterm delivery over laparotomy in the Cagino meta-analysis.[5][6]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]Timmerman D, Ameye L, Fischerova D, et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ, 2010.PMID 21156740
  2. [2]Van Calster B, Van Hoorde K, Valentin L, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ, 2014.PMID 25320247
  3. [3]Barreñada L, Ledger A, Dhiman P, et al. ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies. BMJ Med, 2024.PMID 38375077
  4. [4]Barcroft J, Pandrich M, Del Forno S, et al. Evaluating use of two-step International Ovarian Tumor Analysis strategy to classify adnexal masses identified in pregnancy: pilot study. Ultrasound Obstet Gynecol, 2024.PMID 38787921
  5. [5]Dvash S, Pekar M, Melcer Y, et al. Adnexal Torsion in Pregnancy Managed by Laparoscopy Is Associated with Favorable Obstetric Outcomes. J Minim Invasive Gynecol, 2020.PMID 31563614
  6. [6]Cagino K, Li X, Thomas C, et al. Surgical Management of Adnexal Masses in Pregnancy: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol, 2021.PMID 33515746
  7. [7]Balinskaite V, Bottle A, Sodhi V, et al. The Risk of Adverse Pregnancy Outcomes Following Nonobstetric Surgery During Pregnancy: Estimates From a Retrospective Cohort Study of 6.5 Million Pregnancies. Ann Surg, 2017.PMID 27617856
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute kidney injury in pregnancy — structured SAQ (15 marks)Critical care — renalNextAdnexal mass in early pregnancy — structured SAQ (15 marks)Early pregnancy care